Regulatory Approvals

Regulatory Approvals

FDA Approves Personalized Blood-Test Guided Immunotherapy for Bladder Cancer, Backed by Dana-Farber Science – Dana

Jul 23, 2026

FDA Approves Personalized Blood-Test Guided Immunotherapy for Bladder Cancer, Backed by Dana-Farber Science Dana-Farber Cancer Institute

Regulatory Approvals

FDA Approves Zidesamtinib for Previously Treated ROS1-Positive NSCLC

Jul 23, 2026

FDA Approves Zidesamtinib for Previously Treated ROS1-Positive NSCLC Oncodaily

Regulatory Approvals

FDA Approves Zidesamtinib (Jideytro) for ROS1-Positive Non-Small Cell Lung Cancer

Jul 23, 2026

FDA Approves Zidesamtinib (Jideytro) for ROS1-Positive Non-Small Cell Lung Cancer Oncology News Central

Regulatory Approvals

With FDA approval, Celcuity sees big future for its new breast cancer drug

Jul 23, 2026

With FDA approval, Celcuity sees big future for its new breast cancer drug Star Tribune

Regulatory Approvals

FDA Approves Zidesamtinib in Pretreated ROS1+ NSCLC

Jul 22, 2026

FDA Approves Zidesamtinib in Pretreated ROS1+ NSCLC CancerNetwork

Labor

Labor board won’t block California state worker strike, pending essential worker plan

Labor

California’s move to block SEIU Local 1000 state worker strike likely to fail

Labor

Union election at MedStar Franklin Square too close to call and marred by MedStar Health union busting

Labor

Graduate Student Union Schedules Strike